Top compounds associated with response to FCRLB


Feature Type Standardized
Nominal ANOVA
mRNA Teniposide CTRPv2 pan-cancer AAC -0.097 0.01
mRNA AEW541 CCLE pan-cancer AAC -0.12 0.02
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.086 0.02
mRNA TAE684 GDSC1000 pan-cancer AAC 0.13 0.02
mRNA YM201636 GDSC1000 pan-cancer AAC -0.076 0.02
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.071 0.02
mRNA NSC95397 CTRPv2 pan-cancer AAC -0.075 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.02
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.3 0.02
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.076 0.02
Download CSV